CorCap Efficacy Data Deemed Scant By Panel; Acorn Vows Not To Lose Heart
This article was originally published in The Gray Sheet
Executive Summary
Acorn Cardiovascular will work with FDA to address panel concerns with CorCap that arose during a June 22 meeting to review the ventricular support device